Showing results (201-210 of 559) with videos related to
Sort By:
Pageof 56
JACC. Cardiovascular Interventions|October 22, 2016
Peripheral Revascularization in Patients With Peripheral Artery Disease With Vorapaxar: Insights From the TRA 2°P-TIMI 50 TrialMarc P Bonaca, Mark A Creager, Jeffrey Olin, et al.JAMA Cardiology|July 18, 2019
Effect of Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy After Acute Coronary Syndrome Among Patients 75 Years or Older: A Secondary Analysis of a Randomized Clinical TrialRichard G Bach, Christopher P Cannon, Robert P Giugliano, et al.American Heart Journal|March 29, 2008
Estimated glomerular filtration rate, inflammation, and cardiovascular events after an acute coronary syndromeLisa M Mielniczuk, Marc A Pfeffer, Eldrin F Lewis, et al.Circulation|July 19, 2006
Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor TrialDavid A Morrow, James A de Lemos, Marc S Sabatine, et al.European Heart Journal|August 5, 2006
Benefits of achieving the NCEP optional LDL-C goal among elderly patients with ACSKausik K Ray, Richard G Bach, Christopher P Cannon, et al.American Heart Journal|April 15, 2018
Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trialEric J Velazquez, David A Morrow, Adam D DeVore, et al.European Journal of Heart Failure|August 3, 2022
Atrial amyloidosis: mechanisms and clinical manifestationsGiuseppe Vergaro, Alberto Aimo, Claudio Rapezzi, et al.Circulation|July 24, 2019
Impact of ADCY9 Genotype on Response to AnacetrapibJemma C Hopewell, Maysson Ibrahim, Michael Hill, et al.Journal of the American College of Cardiology|March 19, 2013
Rivaroxaban in patients stabilized after a ST-segment elevation myocardial infarction: results from the ATLAS ACS-2-TIMI-51 trial (Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects with Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction-51)Jessica L Mega, Eugene Braunwald, Sabina A Murphy, et al.European Journal of Heart Failure|February 19, 2019
Klotho, fibroblast growth factor-23, and the renin-angiotensin system - an analysis from the PEACE trialBrian A Bergmark, Jacob A Udell, David A Morrow, et al.Pageof 56